Increased intracellular Cl − concentration mediates neutrophil extracellular traps formation in atherosclerotic cardiovascular diseases

Hui Han,Chang Liu,Mei Li,Jin Wang,Yao-sheng Liu,Yi Zhou,Zi-cheng Li,Rui Hu,Zhi-hong Li,Ruo-mei Wang,Yong-yuan Guan,Bin Zhang,Guan-lei Wang

DOI: https://doi.org/10.1038/s41401-022-00911-9

IF: 7.169

2022-05-06

Acta Pharmacologica Sinica

Abstract:Neutrophil extracellular traps (NETs) play crucial roles in atherosclerotic cardiovascular diseases such as acute coronary syndrome (ACS). Our preliminary study shows that oxidized low-density lipoprotein (oxLDL)-induced NET formation is accompanied by an elevated intracellular Cl − concentration ([Cl − ] i ) and reduced cystic fibrosis transmembrane conductance regulator (CFTR) expression in freshly isolated human blood neutrophils. Herein we investigated whether and how [Cl − ] i regulated NET formation in vitro and in vivo. We showed that neutrophil [Cl − ] i and NET levels were increased in global CFTR null ( Cftr −/− ) mice in the resting state, which was mimicked by intravenous injection of the CFTR inhibitor, CFTR inh -172, in wild-type mice. OxLDL-induced NET formation was aggravated by defective CFTR function. Clamping [Cl − ] i at high levels directly triggered NET formation. Furthermore, we demonstrated that increased [Cl − ] i by CFTR inh -172 or CFTR knockout increased the phosphorylation of serum- and glucocorticoid-inducible protein kinase 1 (SGK1) and generation of intracellular reactive oxygen species in neutrophils, and promoted oxLDL-induced NET formation and pro-inflammatory cytokine production. Consistently, peripheral blood samples obtained from atherosclerotic ApoE −/− mice or stable angina (SA) and ST-elevation ACS (STE-ACS) patients exhibited increased neutrophil [Cl − ] i and SGK1 activity, decreased CFTR expression, and elevated NET levels. VX-661, a CFTR corrector, reduced the NET formation in the peripheral blood sample obtained from oxLDL-injected mice, ApoE −/− atherosclerotic mice or patients with STE-ACS by lowering neutrophil [Cl − ] i . These results demonstrate that elevated neutrophil [Cl − ] i during the development of atherosclerosis and ACS contributes to increased NET formation via Cl − -sensitive SGK1 signaling, suggesting that defective CFTR function might be a novel therapeutic target for atherosclerotic cardiovascular diseases.

pharmacology & pharmacy,chemistry, multidisciplinary